FMC Corporation announced a research agreement with AgroSpheres. The agreement will accelerate the discovery and development of novel bioinsecticides, which is a key part of FMC's long-range strategic plan. The agreement aims to bolster FMC's position as the market leader in insecticides and AgroSpheres' speed to market for its ribonucleic acid (RNA) portfolio by pairing AgroSpheres' production and formulation technology with FMC's high throughput testing, evaluation, and go-to-market capabilities.

In 2023, FMC Venturesinvested in AgroSpheres, a startup developing biodegradable micro-encapsulation technology to improve the delivery, stability and efficacy of biological crop protection products based on RNA interference (RNAi) technology. RNAi biomolecules have demonstrated great promise in the lab but have struggled to yield consistent results for commercial biological development. AgroSpheres' patented AgriCell manufacturing technology allows for the expression of a wide array of RNA molecules while yielding consistent results.

AgroSpheres' production of encapsulated RNA biomolecules delivers enhanced stability, performance and targeted uptake in pests. AgroSpheres' biomodality approach targets specific, yet diverse, biological actions, efficiently multiplying product offerings and innovation.